All eyes were on Lyft (LYFT) as it priced its IPO, along with two biotechs, Genfit (GNFT) and Precision BioSciences (DTIL), in a week that saw positive IPO returns across the board. ...read more
Precision BioSciences, an early stage biotech developing off-the-shelf CAR T cell cancer therapies, raised $126 million by offering 7.9 million shares at $16, the midpoint of the $15 to $17 range. At pricing, the company will command a fully diluted market value...read more
After more than 30 years, iconic jeans brand Levi Strauss & Co. (LEVI) returned the public market this week, along with UPFintech Holding (TIGR) and another SPAC, ...read more
The long-awaited IPO of rideshare giant Lyft (LYFT) will finally hit the market in the week ahead. In total, three IPOs plan to raise roughly $2.3 Billion in the IPO market, a further signal of an IPO market continuing to heat up after roughly...read more
US IPO Weekly Recap: Lyft makes its debut
All eyes were on Lyft (LYFT) as it priced its IPO, along with two biotechs, Genfit (GNFT) and Precision BioSciences (DTIL), in a week that saw positive IPO returns across the board. ...read more
Precision BioSciences prices IPO at $16 midpoint
Precision BioSciences, an early stage biotech developing off-the-shelf CAR T cell cancer therapies, raised $126 million by offering 7.9 million shares at $16, the midpoint of the $15 to $17 range. At pricing, the company will command a fully diluted market value...read more
US IPO Weekly Recap: A pair of jeans and a decacorn
After more than 30 years, iconic jeans brand Levi Strauss & Co. (LEVI) returned the public market this week, along with UP Fintech Holding (TIGR) and another SPAC, ...read more
US IPO Week Ahead: Houston we have Lyft off
The long-awaited IPO of rideshare giant Lyft (LYFT) will finally hit the market in the week ahead. In total, three IPOs plan to raise roughly $2.3 Billion in the IPO market, a further signal of an IPO market continuing to heat up after roughly...read more